Predicting survival of patients with hypocellular myelodysplastic syndrome: development of a disease-specific prognostic score system
about
Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and managementMDS prognostic scoring systems – past, present, and futurePredicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.Validation of the new comprehensive cytogenetic scoring system (NCCSS) on 630 consecutive de novo MDS patients from a single institution.Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher-risk myelodysplastic syndromes.Cytogenetic as an important tool for diagnosis and prognosis for patients with hypocellular primary myelodysplastic syndrome.Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management.Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management.-7/7q- syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity.The myelodysplastic syndromes: the era of understanding.Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes.Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management.
P2860
Q26796240-0E3575A2-3A96-4628-8F1F-5A92412EC2E4Q28082460-D39DF384-45F5-4176-A4FB-53F81EB63E74Q33405470-11C6C3E4-DE21-4212-B3BE-D91EC24F6133Q33405487-D5E6B4EB-5A85-4955-9F00-A8ABABF131A8Q33412937-9277056C-4A70-4C32-A746-6AE4275D0749Q34087088-AC718662-D125-47A2-9EE9-0E9E2DB8C0BEQ37665288-16DF3C4D-E5F7-4862-A367-FBD8BBA860B9Q38018571-496FE35B-FEA9-4195-8E82-F281E484BCF7Q38181996-0ABB7B3A-F6F5-423B-AA61-581834A3400BQ38226741-C7EF4CA4-C31B-46F7-9A76-560B71249E14Q38245878-536110CA-6ABF-47C3-B2EC-2F712DA311D5Q38323957-E9549A68-5F7A-4A40-9304-F37ED9F807CCQ39092515-26A71BA6-4012-442A-A61E-853AF5201F16Q47548041-CBE724D1-85EB-4582-949A-8B5F34C32A1E
P2860
Predicting survival of patients with hypocellular myelodysplastic syndrome: development of a disease-specific prognostic score system
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Predicting survival of patient ...... ecific prognostic score system
@ast
Predicting survival of patient ...... ecific prognostic score system
@en
type
label
Predicting survival of patient ...... ecific prognostic score system
@ast
Predicting survival of patient ...... ecific prognostic score system
@en
prefLabel
Predicting survival of patient ...... ecific prognostic score system
@ast
Predicting survival of patient ...... ecific prognostic score system
@en
P2093
P2860
P50
P356
P1433
P1476
Predicting survival of patient ...... ecific prognostic score system
@en
P2093
Alfonso Quintás-Cardama
Carlos Bueso-Ramos
Jianqin Shan
Wei-Gang Tong
P2860
P304
P356
10.1002/CNCR.27420
P407
P50
P577
2012-01-17T00:00:00Z